Literature DB >> 17604467

Duration of spinal anesthesia with bupivacaine in chronic opium abusers undergoing lower extremity orthopedic surgery.

Ali Dabbagh1, Mastane Dahi-Taleghani, Hedayatollah Elyasi, Maryam Vosoughian, Bahman Malek, Samira Rajaei, Hassan Maftuh.   

Abstract

BACKGROUND: It has been demonstrated that chronic opium abusers have lower thresholds for pain. Spinal anesthesia is a common procedure in anesthesia, which is performed through administration of drugs (usually local anesthetics) in the intrathecal space, to produce temporary pain relief. The aim of this study was to determine whether chronic opium abuse could have any possible effect on the duration of spinal block by bupivacaine.
METHODS: In a case-control study, 50 opium abusers and 50 nonabusers undergoing lower extremity orthopedic operations were selected from the patients admitted in Taleghani Hospital in Tehran for elective surgery. The study parameters were assimilated as much as possible, including the method of anesthesia.
RESULTS: No statistically significant difference was noted between the two groups regarding the age, sex, and duration of surgery; while, the duration of sensory block was much shorter in the opium abusers (86.6+/-15.7 minutes) compared with the nonabusers (162+/-22.1 minutes) (P<0.0001).
CONCLUSION: The study suggests a shortened duration of spinal block with bupivacaine in opium abusers. The results can propose a number of possible mechanisms including cross-tolerance mechanisms between local anesthetics and opioid compounds at the level of spinal neurons. Further molecular studies at the level of spine are suggested.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17604467     DOI: 07103/AIM.007

Source DB:  PubMed          Journal:  Arch Iran Med        ISSN: 1029-2977            Impact factor:   1.354


  8 in total

1.  Can repeated exposure to morphine change the spinal analgesic effects of lidocaine in rats?

Authors:  Ali Dabbagh; Shervin Farkhondehkish Moghadam; Samira Rajaei; Zahra Mansouri; Homa Shardi Manaheji
Journal:  J Res Med Sci       Date:  2011-10       Impact factor: 1.852

2.  The effect of pretreatment with clonidine on propofol consumption in opium abuser and non-abuser patients undergoing elective leg surgery.

Authors:  Morteza Jabbari Moghadam; Davood Ommi; Alireza Mirkheshti; Mehdi Shadnoush; Ali Dabbagh
Journal:  J Res Med Sci       Date:  2012-08       Impact factor: 1.852

3.  The effect of adjuvant midazolam compared with fentanyl on the duration of spinal anesthesia with 0.5% bupivacaine in opium abusers.

Authors:  Farhad Safari; Ali Dabbagh; Mansour Sharifnia
Journal:  Korean J Anesthesiol       Date:  2012-12-14

4.  The Effect of Adding Sufentanil to 0.5% Hyperbaric Bupivacaine on Duration of Brachial Plexus Blockade in Chronic Opium Abusers: a Randomized Clinical Trial.

Authors:  Omid Azimaraghi; Seyed Mojtaba Marashi; Noushin Khazaei; Sarah Pourhassan; Ali Movafegh
Journal:  Anesth Pain Med       Date:  2015-06-22

5.  Effectiveness of local anesthesia with lidocaine in chronic opium abusers.

Authors:  Amir Masoud Hashemian; Ali Omraninava; Ali Darvishpoor Kakhki; Mohammad Davood Sharifi; Koorosh Ahmadi; Babak Masoumi; Omid Mehrpour
Journal:  J Emerg Trauma Shock       Date:  2014-10

6.  Cerebrospinal Fluid and Spinal Anesthesia Parameters in Healthy Individuals versus Opium-addict Patients during Lower Limb Surgery.

Authors:  Pooya Derakhshan; Farnad Imani; Seyed Alireza Seyed-Siamdoust; Sorour Garousi; Nasrin Nouri
Journal:  Addict Health       Date:  2020-01

7.  Effect of intravenous patient controlled ketamine analgesiaon postoperative pain in opium abusers.

Authors:  Mastane Dahi-Taleghani; Benjamin Fazli; Mahshid Ghasemi; Maryam Vosoughian; Ali Dabbagh
Journal:  Anesth Pain Med       Date:  2014-02-15

8.  What Is the Main Reason for Reduction in Duration of Action of Local Anesthetics Used for Spinal Anesthesia in Opium Addicted Patients?

Authors:  Samaneh Kouzehgaran; Amir Saber-Tanha
Journal:  Addict Health       Date:  2015 Summer-Autumn
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.